Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04925609
Title	Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors (Briga-PED)
Acronym	Briga-PED
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Princess Maxima Center for Pediatric Oncology
Indications	Advanced Solid Tumor inflammatory myofibroblastic tumor anaplastic large cell lymphoma
Therapies	Brigatinib
Age Groups:	child \| adult
Covered Countries	NLD \| FRA